eNauka - pregled
Pregled prema Autor Milenkovic, D
Prikaz rezultata 1 do 3 od 3
| Godina | Naslov | Autor(i) | Tip rezultata | Mp-kat. |
|---|---|---|---|---|
| 2026 | OPTIMAL: a multinational phase III study of oral paclitaxel (DHP107) versus intravenous weekly paclitaxel in HER2-negative recurrent or metastatic breast cancer | Xu, B; ...; Kostic, S; ...; Milenkovic, D; ...; (broj, koautora 21) | Naučni članak | 21a+M21a+ - Vodeći međunarodni časopis kategorije M21a+ |
| 2025 | Real-world treatment patterns in patients with human epidermal growth factor receptor 2 (HER2) - positive early breast cancer in Serbia and Montenegro - HEReNA | Bozovic-Spasojevic, I   ; Milovic-Kovacevic, M ; Lekic, S; Cvetanovic, A ; Kolarov-Bjelobrk, Ivana ; Lucic, J; Andric, Z ; Milenkovic, D; ...; Vukovic, I;
Petronijevic, M; Calamac, M; Djurmez, O; Djuric, S
; Perduv, V; Radisavljevic, M; Popovic, Lazar ; | Konferencijski rad | Mp kategorija će biti prikazana naknadno. |
| 2019 | Trilaciclib (T), a CDK4/6 inhibitor, dosed with gemcitabine (G), carboplatin (C) in metastatic triple negative breast cancer (mTNBC) patients: Preliminary phase 2 results | O'Shaughnessy, J; ...; Popovic, Lazar S ; ...; Vojnovic, Z; ...; Milenkovic, D; ...; (broj, koautora 23) | Konferencijski rad | Mp kategorija će biti prikazana naknadno. |